China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping further gains.

May was a volatile but ultimately flat month for gold (XAUUSD). Monthly Doji candlestick signals indecision. U.S. trade ...

The major averages posted modest gains on Thursday, placing them on track for a winning week. Softer-than-anticipated inflation reports helped lift stocks.

Policymakers are expected to stand pat on rates, but the devil will be in the detail of its statement and Governor Kazuo Ueda ...

Asian equity-index futures were buoyed by gains in stocks and bonds on Wall Street as further signs of cooling US inflation ...

Australian shares are set to open higher, tracking modestly positive sentiment in New York. US PPI data affirms muted ...

The PGIM Select Real Estate Fund underperformed the benchmark, the FTSE EPRA/NAREIT Developed Index, for the first quarter of ...

The G7 summit brings into focus how Canada and other countries in the decades-old alliance are hoping to build trade deals in ...

Despite evolving US-China-India tariff dynamics, markets remain largely unaffected, according to Mark Matthews of Julius Baer ...

Global shares are mostly trading higher after China and the U.S. said they have a framework for following up on the trade ...

Against this backdrop, the Goldman specialist flags some "choppiness" appearing "under the hood" of current market trends, such as the Cboe Volatility Index VIX, or the so-called fear index, that ...

US and China agree on a framework to implement their trade truce, focusing on export controls and rare earth minerals.